ARSB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.565400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.203230E-01
Normal-vs-Stage2
3.008200E-01
Normal-vs-Stage3
2.758800E-01
Normal-vs-Stage4
7.636200E-01
Stage1-vs-Stage2
4.632600E-01
Stage1-vs-Stage3
9.388800E-01
Stage1-vs-Stage4
2.856200E-01
Stage2-vs-Stage3
5.942000E-01
Stage2-vs-Stage4
5.269200E-01
Stage3-vs-Stage4
4.493400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.168200E-01
Normal-vs-AfricanAmerican
5.918600E-01
Normal-vs-Asian
3.300200E-01
Caucasian-vs-AfricanAmerican
6.605600E-01
Caucasian-vs-Asian
6.279800E-01
AfricanAmerican-vs-Asian
5.856000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.210200E-01
Normal-vs-Female
3.292000E-01
Male-vs-Female
3.082200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.412400E-01
Normal-vs-Age(41-60Yrs)
4.611000E-01
Normal-vs-Age(61-80Yrs)
1.983190E-01
Normal-vs-Age(81-100Yrs)
2.870800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.439000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.741200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.477400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.613900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.219600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.323000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.170370E-01
Normal-vs-Daily Drinker
8.639600E-02
Normal-vs-Weekly Drinker
6.530600E-01
Normal-vs-Occasional Drinker
1.850760E-01
Normal-vs-Social Drinker
7.607800E-01
Non Drinker-vs-Daily Drinker
6.428200E-01
Non Drinker-vs-Weekly Drinker
9.846400E-02
Non Drinker-vs-Occasional Drinker
7.079200E-01
Non Drinker-vs-Social Drinker
2.864200E-02
Daily Drinker-vs-Weekly Drinker
6.358000E-02
Daily Drinker-vs-Occasional Drinker
4.461400E-01
Daily Drinker-vs-Social Drinker
1.743590E-02
Weekly Drinker-vs-Occasional Drinker
2.340600E-01
Weekly Drinker-vs-Social Drinker
7.458200E-01
Occasional Drinker-vs-Social Drinker
9.540100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.357000E-01
Normal-vs-Grade 2
4.723400E-01
Normal-vs-Grade 3
4.901800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.249800E-01
Grade 1-vs-Grade 3
3.558600E-01
Grade 1-vs-Grade 4
7.357000E-01
Grade 2-vs-Grade 3
7.846400E-01
Grade 2-vs-Grade 4
4.723400E-01
Grade 3-vs-Grade 4
4.901800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.494800E-01
Normal-vs-NonDiabetic
1.753420E-01
Diabetic-vs-NonDiabetic
4.596000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.611800E-01
Normal-vs-NoPancreatitis
2.335800E-01
Pancreatitis-vs-NoPancreatitis
4.127400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.200810E-01
Normal-vs-N1
3.167800E-01
N0-vs-N1
7.256300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.937800E-02
Normal-vs-TP53-NonMutant
1.878400E-01
TP53-Mutant-vs-TP53-NonMutant
1.187770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
